Aquaporin 1, Aquaporin 3 and Aquaporin 5 expression and EGFR mutation in malignant pleural mesotheliomas: an imunohistochemical and molecular study

References

• Price B, Ware A. Time trend of mesothelioma incidence in the United States and projection of future cases: an update based on SEER data for 1973 through 2005. Critical Rev Toxicol. 2009;39:576–588.
   PubMed Web of Science ®Google Scholar
• Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomized feasibility study. Lancet Oncol. 2011;12:763–772.
   PubMed Web of Science ®Google Scholar
• Taioli E, Wolf AS, Camacho-Rivera M, et al. Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) study of 14,228 patients. PLoS One. [Internet]. 2015 [ cited 2016 Nov 19];10:e0145039. Available from: http://journals.plos.org/plosone/article?id = 10.1371/journal.pone.0145039
   Google Scholar
• Stahel RA, Weder W, Felley-Bosco E, et al. Searching for targets for the systemic therapy of mesothelioma. Ann Oncol. 2015;26:1649–1660.
   PubMed Web of Science ®Google Scholar
• Verkman AS, Mitra AK. Structure and function of aquaporin water channels. Am J Physiol Renal Physiol. 2000;278:13–28.
   PubMed Web of Science ®Google Scholar
• King LS, Kozono D, Agre P. From structure to disease: the evolving tale of aquaporin biology. Nat Rev Mol Cell Biol. 2004;5:687–698.
   PubMed Web of Science ®Google Scholar
• Huang YT, Zhou J, Shi S, et al. Identification of estrogen response element in Aquaporin-3 gene that mediates estrogen-induced cell migration and ınvasion in estrogen receptor-positive breast cancer. Sci Rep. [Internet]. 2015 [ cited 2016 Nov 19];5:12484. Available from: http://www.nature.com/articles/srep12484
   PubMed Web of Science ®Google Scholar
• Saadoun S, Papadopoulos MC, Hara-Chikuma M, et al. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature. 2005;434:786–792.
   PubMed Web of Science ®Google Scholar
• Hu J, Verkman AS. Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. FASEB J. 2006;20:1892–1894.
   PubMed Web of Science ®Google Scholar
• Verkman AS, Hara-Chikuma M, Papadopoulos MC. Aquaporins – new players in cancer biology. J Mol Med (Berl). 2008;86:523–529.
   PubMed Web of Science ®Google Scholar
• Machida Y, Ueda Y, Shimasaki M, et al. Relationship of aquaporin 1, 3, and 5 expression in lung cancer cells to cellular differentiation, invasive growth, and metastasis potential. Hum Pathol. 2011;42:669–678.
   PubMed Web of Science ®Google Scholar
• Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350:2129–2139.
   PubMed Web of Science ®Google Scholar
• Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304:1497–1500.
   PubMed Web of Science ®Google Scholar
• Lee JW, Soung YH, Kim SY, et al. Somatic mutations of EGFR gene in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2005;11:2879–2882.
   PubMed Web of Science ®Google Scholar
• Rena O, Boldorini LR, Gaudino E, et al. Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations. J Surg Oncol. 2011;104:701–705.
   PubMed Web of Science ®Google Scholar
• Enomoto Y, Kasai T, Takeda M, et al. A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma. Pathol Int. 2012;62:226–231.
   PubMed Web of Science ®Google Scholar
• Galateau-Salle F, Churg A, Roggli V, et al. The 2015 World Health Organization Classification of Tumors of the Pleura: advances since the 2004 classification. J Thorac Oncol. 2016;11:142–154.
   PubMed Web of Science ®Google Scholar
• Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J. 2010;35:479–495.
   PubMed Web of Science ®Google Scholar
• Özler A, Evsen MS, Turgut A, et al. CD147 expression in uterine smooth muscle tumors, and its potential role as a diagnostic and prognostic marker in patients with leiomyosarcoma. J Exp Ther Oncol. 2014;10:325–330.
   PubMedGoogle Scholar
• Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636–2644.
   PubMed Web of Science ®Google Scholar
• Matsuzaki T, Tajika Y, Ablimit A, et al. Aquaporins in the digestive system. Med Electron Microsc. 2004;37:71–80.
   PubMedGoogle Scholar
• Mobasheri A, Airley R, Hewitt SM, et al. Heterogeneous expression of the aquaporin 1 (AQP 1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays. Int J Oncol. 2005;26:1149–1158.
   PubMed Web of Science ®Google Scholar
• Kao SC, Armstrong N, Condon B, et al. Aquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma. Cancer. 2012;118:2952–2961.
   PubMed Web of Science ®Google Scholar
• Litman T, Sogaard R, Zeuthen T. Ammonia and urea permeability of mammalian aquaporins. Handb Exp Pharmacol. 2009;190:327–358.
   PubMedGoogle Scholar
• Wang G, Gao F, Zhang W, et al. Involvement of aquaporin 3 in Helicobacter pylori-related gastric diseases. PLoS One. [ Internet]. 2012 [ cited 2016 Aug 23];7:e49104. Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0049104
   PubMed Web of Science ®Google Scholar
• Kusayama M, Wada K, Nagata M, et al. Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma. Cancer Sci. 2011;102:1128–1136.
   PubMed Web of Science ®Google Scholar
• Shi YH, Chen R, Talafu T, et al. Significance and expression of aquaporin 1, 3, 8 in cervical carcinoma in Xinjiang Uygur women of China. Asian Pac J Cancer Prev. 2012;13:1971–1975.
   PubMed Web of Science ®Google Scholar
• Niu D, Kondo T, Nakazawa T, et al. Differential expression of aquaporins and its diagnostic utility in thyroid cancer. PLoS One. [Internet]. 2012 [ cited 2016 Aug 23];7:e40770. Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0040770
   Google Scholar
• Liu W, Wang K, Gong K, et al. Epidermal growth factor enhances MPC-83 pancreatic cancer cell migration through the up-regulation of aquaporin 3. Mol Med Rep. 2012;6:607–610.
   PubMed Web of Science ®Google Scholar
• Ismail M, Bokaee S, Morgan R, et al. Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy. Br J Cancer. 2009;100:1889–1895.
   PubMed Web of Science ®Google Scholar
• Ji C, Cao C, Lu S, et al. Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells. Cancer Chemother Pharmacol. 2008;62:857–865.
   PubMed Web of Science ®Google Scholar
• Hara-Chikuma M, Verkman AS. Prevention of skin tumorigenesis and impairment of epidermal cell proliferation by targeted aquaporin-3 gene disruption. Mol Cell Biol. 2008;28:326–332.
   PubMed Web of Science ®Google Scholar
• Janosi L, Ceccarelli M. The gating mechanism of the human aquaporin 5 revealed by molecular dynamics simulations. PLoS One. [Internet]. 2013 [ cited 2016 Aug 23];8:e59897. Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0059897
   PubMed Web of Science ®Google Scholar
• Matsuzaki T, Susa T, Shimizu K, et al. Function of the membrane water channel aquaporin-5 in the salivary gland. Acta Histochem Cytochem. 2012;45:251–259.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen Z, Song Y, et al. Expression of aquaporin 5 increases proliferation and metastasis potential of lung cancer. J Pathol. 2010;221:210–220.
   PubMed Web of Science ®Google Scholar
• Kang SK, Chae YK, Woo J, et al. Role of human aquaporin 5 in colorectal carcinogenesis. Am J Pathol. 2008;173:518–525.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Fujii T, Oya T, et al. Involvement of aquaporin-5 in differentiation of human gastric cancer cells. J Physiol Sci. 2009;59:113–122.
   PubMed Web of Science ®Google Scholar
• Yang JH, Shi YF, Cheng Q, et al. Expression and localization of aquaporin-5 in the epithelial ovarian tumors. Gynecol Oncol. 2006;100:294–299.
   PubMed Web of Science ®Google Scholar
• Boon K, Edwards JB, Eberhart CG, et al. Identification of astrocytoma associated genes including cell surface markers. BMC Cancer. [Internet]. 2004 [ cited 2016 Aug 23];4:39. Available from: http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-4-39
   PubMed Web of Science ®Google Scholar
• Moon C, Soria JC, Jang SJ, et al. Involvement of aquaporins in colorectal carcinogenesis. Oncogene. 2003;22:6699–6703.
   PubMed Web of Science ®Google Scholar
• Shen L, Zhu Z, Huang Y, et al. Expression profile of multiple aquaporins in human gastric carcinoma and its clinical significance. Biomed Pharmacother. 2010;64:313–318.
   PubMed Web of Science ®Google Scholar
• Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. Erlotinib in previously treated nonsmall-cell lung cancer. N Engl J Med. 2005;353:123–132.
   PubMed Web of Science ®Google Scholar
• Dazzi H, Hasleton PS, Thatcher N, et al. Malignant pleural mesothelioma and epidermal growth factor receptor (EGFR). Relationship of EGFR with histology and survival using fixed paraffin-embedded tissue and the F4, monoclonal antibody. Br J Cancer. 1990;61:924–926.
   PubMed Web of Science ®Google Scholar
• Okuda K, Sasaki H, Dumontet C, et al. Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma. J Cancer Res Clin Oncol. 2008;134:1105–1111.
   PubMed Web of Science ®Google Scholar
• Cortese JF, Gowda AL, Wali A, et al. Common EGFR mutations conferring sensitivity to gefitinib in lung adenocarcinoma are not prevalent in human malignant mesothelioma. Int J Cancer. 2006;118:521–522.
   PubMed Web of Science ®Google Scholar
• Velcheti V, Kasai Y, Viswanathan AK, et al. Absence of mutations in the epidermal growth factor receptor (EGFR) kinase domain in patients with mesothelioma. J Thorac Oncol. 2009;4:559.
   PubMed Web of Science ®Google Scholar
• Enomoto Y, Kasai T, Takeda M, et al. Epidermal growth factor receptor mutations in malignant pleural and peritoneal mesothelioma. J Clin Pathol. 2012;65:522–527.
   PubMed Web of Science ®Google Scholar
• Mezzapelle R, Miglio U, Rena O, et al. Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma. Br J Cancer. 2013;108:1743–1749.
   PubMed Web of Science ®Google Scholar
• Barbieri F, Wurth R, Favoni RE, et al. Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets. Biochem Pharmacol. 2011;82:1467–1477.
   PubMed Web of Science ®Google Scholar
• Govindan R, Kratzke RA, Herndon JE, et al. Gefitinib in patients with malignant mesothelioma: a phase II study by the cancer and leukemia group B. Clin Cancer Res. 2005;11:2300–2304.
   PubMed Web of Science ®Google Scholar
• Garland LL, Rankin C, Gandara DR, et al. Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. J Clin Oncol. 2007;25:2406–2413.
   PubMed Web of Science ®Google Scholar